AXSM FY 2020 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AXSMAxsome Therapeutics, Inc.

$9B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$99M

Net Income

-$103M

EPS (Diluted)

$-2.83

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$79M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$186M

Total Liabilities

$72M

Stockholders' Equity

$114M

Cash & Equivalents

$184M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$37,330	+100.0%
Operating Income	-$99M	-$67M	-47.4%
Net Income	-$103M	-$68M	-50.6%